Improved radioimaging and tumor localization with monoclonal F(ab')2

Area of Science:

• Oncology
• Immunology
• Radiopharmaceuticals

Background:

• Monoclonal antibodies (mAbs) are promising for tumor radioimmunodetection and localization.
• Antibody fragments (Fab and F(ab')2) lack the Fc region, potentially improving clearance and reducing non-specific binding compared to intact antibodies (Ab).

Purpose of the Study:

• To compare the efficacy of intact monoclonal antibodies, Fab fragments, and F(ab')2 fragments for radioimmunodetection of tumors.
• To evaluate the speed and specificity of tumor localization using different antibody formats.

Main Methods:

• Radioimaging studies using a murine monoclonal antibody targeting carcinoembryonic antigen (CEA).
• Experiments involved human colon carcinoma xenografts in hamsters.
• Comparison of intact antibody, Fab, and F(ab')2 fragments in scintiscanning and double-label experiments.

Main Results:

• F(ab')2 fragments demonstrated superior performance over Fab fragments and intact antibodies in scintiscanning for tumor imaging.
• Double-label experiments confirmed that F(ab')2 fragments achieved better and faster specific tumor localization than intact antibodies or Fab fragments.
• Reduced non-specific tissue binding and rapid circulation clearance were observed with antibody fragments.

Conclusions:

• F(ab')2 fragments are highly effective for radioimmunodetection and localization of tumors.
• These fragments offer significant advantages for tumor imaging applications.
• F(ab')2 fragments hold promise for future tumor therapy strategies.